⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
Latest News
Absci Announces Preliminary Details for Phase 2 STORYLINE™ Trial of AI-Designed Antibody ABS-201™ for Endometriosis
globenewswire.com
ABSI
EBANX advances emerging market infrastructure with Pakistan expansion in motion and native Apple Pay decryption
globenewswire.com
AAPL
Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces Upcoming Late-Breaking Presentation of MAR001 Clinical Data at the American Heart Association Scientific Sessions 2026
globenewswire.com
LSTA
Cadillac Mines Appoints Pierre Beaudoin to Board of Directors
globenewswire.com
CSTL
AGNC
GFI
SL Science Presents Preclinical Data at the 85th Annual Meeting of the Japanese Cancer Association Showing γδ T Cells Target Chemotherapy-Resistant Glioblastoma
globenewswire.com
SLBT
VisionWave Holdings Receives $20 Million Purchase Order for 200 STRATUM VARAN Unmanned Ground Vehicles, Subject to Conditions
globenewswire.com
VWAV
Nuvectis Announces NXP200 Granted Breakthrough Therapy Designation in China for BRAF V600-Mutant, Recurrent or Progressive, High-Grade Glioma
globenewswire.com
NVCT
Quantum Biopharma Licensee Unbuzzd Wellness to Advance Clinically Validated Alcohol Metabolism Accelerant After Appointing Zappy as CEO
globenewswire.com
QNTM
New Preclinical Data Further Support Potential for Tvardi’s STAT3 Inhibitors in Ulcerative Colitis (UC)
globenewswire.com
TVRD
Annexon to Present Patient Baseline Characteristics from Vonaprument Phase 3 ARCHER II Pivotal Trial for Geographic Atrophy at The Retina Society 59th Annual Scientific Meeting
globenewswire.com
ANNX